Potential biomarkers screening to predict side effects of dexamethasone in different cancers
ConclusionsWARS1 andCDC25A might be potential biomarkers for side effects of dexamethasone in lymphoma, andHELZ2 in prostate cancer.
Source: Molecular Genetics & Genomic Medicine - Category: Genetics & Stem Cells Authors: Da Jiang,
Hui Jin,
Jing Zuo,
Yan Kong,
Xue Zhang,
Qian Dong,
Zhihong Xu,
Ying Li Tags: ORIGINAL ARTICLE Source Type: research
More News: Cancer | Cancer & Oncology | Databases & Libraries | Dexamethasone | Genetics | Insulin | Lymphoma | Prostate Cancer | Study